Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)

BACKGROUND AND AIMS: Teneligliptin was introduced in India in May 2015. It has gained popularity and is already widely prescribed in type 2 diabetes mellitus (T2DM). This “real life” data collection was conducted to assess the efficacy of teneligliptin in Indian T2DM patients. METHODS: Predesigned s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Sujoy, Trivedi, Shailesh, Sanyal, Debmalya, Modi, KD, Kharb, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108474/
https://www.ncbi.nlm.nih.gov/pubmed/27877058
http://dx.doi.org/10.2147/DMSO.S121770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108474/
https://www.ncbi.nlm.nih.gov/pubmed/27877058
http://dx.doi.org/10.2147/DMSO.S121770

Ejemplares similares